Annual Report 2020

CONSOLIDATEDSTATEMENT OFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME For the year ended 31 December 2020 38 The United Laboratories International Holdings Limited Annual Report 2020 2020 2019 NOTES RMB’000 RMB’000 Revenue 5 8,772,488 8,392,600 Cost of sales (4,966,270) (4,771,336) Gross profit 3,806,218 3,621,264 Other income 6 202,350 123,059 Other gains and losses, net 7a 14,617 (1,773) Selling and distribution expenses (1,483,868) (1,477,637) Administrative expenses (742,002) (740,653) Other expenses 7b (353,182) (386,829) Impairment losses under expected credit loss model, net of reversal 9 (65,912) (7,655) Gain on disposal of a subsidiary 10 – 200,445 Loss on fair value change on investment properties 19 – (97,614) Loss on fair value change of embedded derivative components of convertible bonds 30 (314,614) (110,117) Finance costs 8 (181,273) (280,838) Profit before taxation 882,334 841,652 Tax expense 11 (181,416) (199,888) Profit for the year 12 700,918 641,764 Other comprehensive income (expense) Item that may be reclassified subsequently to profit or loss: Exchange differences arising on translation of foreign operations 5,904 (1,971) Total comprehensive income for the year 706,822 639,793